Stevanato Group Files Amendment No.1 to Its 2021 Annual Report on Form 20‑F/A
April 05 2022 - 7:30AM
Business Wire
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider
of drug containment, drug delivery, and diagnostic solutions to the
pharmaceutical, biotechnology, and life sciences industries,
announced the filing of Amendment No. 1 (the “Form 20-F/A”) to its
2021 Annual Report on Form 20-F (the “Form 20-F”), which was filed
with the U.S. Securities and Exchange Commission (the “SEC”) on
March 8, 2022, to submit the Interactive Data File and to provide
certain additional information as described in the explanatory note
thereto.
Stevanato Group filed the Form 20-F/A with the SEC on April 5,
2022 (www.sec.gov). The Form 20-F/A will be available to
shareholders and other interested parties at
www.stevanatogroup.com. A printed copy can be obtained free of
charge upon written request to the following email address
ir@stevanatogroup.com.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of
drug containment, drug delivery and diagnostic solutions to the
pharmaceutical, biotechnology and life sciences industries. The
Group delivers an integrated, end-to-end portfolio of products,
processes and services that address customer needs across the
entire drug life cycle at each of the development, clinical and
commercial stages. Stevanato Group’s core capabilities in
scientific research and development, its commitment to technical
innovation and its engineering excellence are central to its
ability to offer value added solutions to clients. For more
information, please visit www.stevanatogroup.com
Forward-Looking Statements
This press release contains certain forward-looking statements
which include, or may include, words such as "raising", "believe",
"potential", "increased", "future", "remain", "growing", "expect",
"foreseeable", "expected", "to be", "includes", "estimated",
"assumes", "would provide", and other similar terminology.
Forward-looking statements contained in this press release include,
but are not limited to, statements about: our future financial
performance, including our revenue, operating expenses, and our
ability to maintain profitability and operational and commercial
capabilities; our expectations regarding the development of our
industry and the competitive environment in which we operate; and
our goals, strategies, and investment plans.
These forward-looking statements speak only as at their dates.
Stevanato Group undertakes no obligation to update any
forward-looking statement or statements to reflect events or
circumstances after the date on which such statement is made or to
reflect the occurrence of unanticipated events. New factors emerge
from time to time, and it is not possible to predict all of these
factors. Further, Stevanato Group cannot assess the impact of each
such factor on our business or the extent to which any factor, or
combination of factors, may cause actual results to be materially
different from those contained in any forward-looking
statements.
For a description of certain additional factors that could cause
Stevanato Group’s future results to differ from those expressed in
any such forward-looking statements, see Item 3D. entitled "Risk
Factors" in the Company's Annual Report on Form 20-F for the year
ended December 31, 2021, as amended, filed with the SEC.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220405005741/en/
Media Stevanato Group media@stevanatogroup.com
Investor Relations Lisa Miles
lisa.miles@stevanatogroup.com
Stevanato (NYSE:STVN)
Historical Stock Chart
From Apr 2024 to May 2024
Stevanato (NYSE:STVN)
Historical Stock Chart
From May 2023 to May 2024